Cann American Corp. (CNNA) Research

Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.

Market snapshot

Symbol
CNNA
Price
$0.00
Day change
-38.78%
Market cap
$2.2M
P/E ratio
0.24x
52-week range
0.0001-0.0077
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Allied Corp. (ALID)
  • Applied Biosciences Corp. (APPB)
  • Target Group Inc. (CBDY)
  • CannaPharmaRX, Inc. (CPMD)
  • Enzolytics Inc. (ENZC)
  • James E. Wagner Cultivation Corporation (JWCAF)
  • MJardin Group, Inc. (MJARF)
  • Mystic Holdings, Inc. (MSTH)

Recent insider activity

  • DAHLERUP HENRIK — trade (0 shares) on 2011-01-25
  • SCHIORRING KRISTIAN — trade (0 shares) on 2011-01-25
  • WONG GARRY E — S-Sale (12856667 shares) on 2011-01-25
  • WONG GARRY E — S-Sale (75643333 shares) on 2011-01-25
  • WONG GARRY E — trade (0 shares) on 2011-01-25

Open Cann American Corp. (CNNA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.